US experts urge expanding flu vacc season

6 July 2008

Health care professionals should increase influenza immunization rates by implementing key, practice-proven interventions and offering vaccine at every opportunity throughout the entire influenza season, conclude leading influenza experts in a July 2008 supplement to the American Journal of Medicine. The experts assert that the medical community is not taking advantage of routine office visits to immunize all recommended individuals against a disease that causes more than 200,000 hospitalizations and more than 36,000 deaths in the USA every year. This year, more people are recommended for influenza vaccination than ever before - nearly 250 million Americans.

Although the supplement contributors each emphasize different aspects of influenza immunization, all underscore the need for vaccine to be offered by health care providers from October through January and beyond. The recommendation supports guidelines from the US Centers for Disease Control and Prevention (CDC) and is aimed at reducing influenza-related illness and death, particularly among high-risk populations such as children, the elderly and those with chronic conditions.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight